Meeting Banner
Abstract #3632

Differentiating Pseudoprogression from True Progression Using DTI and DSC-MRI

Sumei Wang1, Sanjeev Chawla1, Sungheon Kim2, Arati Desai3, Michelle Alonso-Basanta4, Maria Martinez-Lage5, Steven Brem6, Elias R. Melhem1, 7, Harish Poptani1

1Radiology, University of Pennsylvania, Philadelphia, PA, United States; 2Radiology, New York University School of Medicine, New York, NY, United States; 3Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, United States; 4Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States; 5Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States; 6Neurosurgery, University of Pennsylvania, Philadelphia, PA, United States; 7Radiology, University of Maryland, Baltimore, MD, United States

The purpose of this study was to determine whether diffusion and perfusion MRI can help in differentiating pseudoprogression (PsP) from true progression (TP) in glioblastoma patients demonstrating enhancing lesions within six months post chemo-radiation therapy. Six patients with PsP and 7 patients with TP underwent DTI and DSC-MRI studies. Significantly elevated median mean diffusivity (MD) and decreased rCBV from the enhancing part of the tumor was observed in patients with PsP compared with TP, indicating that DTI and DSC may be helpful in differentiating PsP from TP.

Abstract PDF Presentation Video

Keywords

abundant acceleration accurate accurately allow appearance appears array arrows avoided biopsy brain care caused channel characteristics characterized chemotherapy circles clinical coil concomitant consistent continue contrast corrected covering criteria critical databases determine diagnosed diagnosis differentiating diffusion distribution dose dynamic edema edges elevated enhanced enhancement enhancing features final generated gradient hand head helpful hematology house identification identify included indicates induced ineffective initiation injection inside institutional laboratory leakage lesions macrophages management maps materials measured median medicine metrics mimic mitoses modeling monitored months necrosis needed neurosurgery newly nuclear often oncology outcome outliers pair parallel part pass pathologic pathologically patient patients percentiles perfusion placement plot preliminary previous progression radiation radiology rather reach reaction reactive regimen registered related repeat reported reports representative resection resolution school seven shot significantly slice slices software solid straight studies surgery surgical susceptibility tend termination therapeutic therapy thirteen treatment trio true tumor typically undergone underwent unnecessary useful validate viable whereas whether white wise